PRIORITY JEWELS LIMITED

Consumer Cyclical — Luxury Goods · NSE

₹356.75+₹15.30 (+4.48%)

DalalBaazaar Score

58 / 100

🟡 Moderate

Verdict

NEUTRAL

Risk

Moderate

Driven by micro-cap size, which brings thin liquidity.

In simple words: Strong business and financial position, with both sales and profits growing well. Nothing on this snapshot stands out as an immediate concern — the usual checks on business quality and management still apply.

Decision support, not a buy or sell call.

As of 18 Oct 2026, 6:05 pm

Constructive picture on fundamentals. Profitability, leverage and growth metrics are broadly healthy on this snapshot. That said, valuation should still be checked against direct sector peers (not just the generic P/E bands used here) before treating this as a buy signal.

Understanding the Business

Company site ↗

The 60-second version of PRIORITY JEWELS LIMITED — what it does, how it earns, and who it competes with, before any of the numbers below.

What does this company do?

Priority Jewels Limited engages in the designing, manufacturing, and sale of diamond-studded gold and platinum fine jewellery in India.

IndustryLuxury Goods

SectorConsumer Cyclical

Employees211

Annual revenue₹529 Cr

How does it make money?

Turns over ₹529 Cr a year. Of every ₹100 of sales, about ₹3 reaches shareholders as profit, with ₹6 left at the operating level before interest, tax and depreciation. Each of its 211 employees supports ₹2.51 Cr of revenue a year, the signature of a capital- or asset-led business.

EBITDA margin6.3%

Net margin3.4%

Revenue / employee₹2.51 Cr

Who are its competitors?

The closest listed comparisons in its industry are TITAN COMPANY LIMITED, TRENT LTD, AVENUE SUPERMARTS LIMITED, ASIAN PAINTS LIMITED. These are the companies its valuation and returns are measured against elsewhere in this report.

TITAN COMPANY LIMITEDP/E 68.5x · ROE 36.7%

TRENT LTDP/E 87.2x · ROE 25.9%

AVENUE SUPERMARTS LIMITEDP/E 69.9x · ROE 12.7%

ASIAN PAINTS LIMITEDP/E 46.9x · ROE 22.3%

What is its competitive advantage?Some evidence

ROCE of 20.6% is above what capital typically costs, which suggests some pricing power, though not yet the sustained, wide gap that marks a durable advantage.

ROCE20.6%

ROE12.8%

Peer median ROE25.9%

What has been driving growth?

Profit has moved mainly because margins changed, not because the business sold much more. Over 3 years revenue moved +14% while net margin moved +247% relative to itself. What this cannot tell you is which products, customers or geographies did the work — that lives in the segment disclosures of the annual report.

Revenue effect+14%

Margin effect+247%

DalalBaazaar Score

58/ 100

Moderate

Weighted across six categories. Every point is explained below.

✗ Micro Cap: thinner liquidity and sharper drawdowns are normal

Quality vs. Valuation

Company Quality

65/ 100

Good

How good the business is, ignoring the share price entirely.

Valuation

63/ 100

Fair

What you are being asked to pay, ignoring how good the business is.

A reasonable business at a reasonable price — neither the quality nor the valuation stands out in either direction.

Historical Valuation

Current P/E

37.5x

Sector Median

69.2x

median of 4 sector peers

🟢Against its sector it trades 46% below the peer median of 69.2x.

vs. its own history

Not enough price and earnings history

vs. sector peers

Cheap

69.2x median of 4 peers · -46%

vs. generic bands

Expensive

Above 35x

P/E (Trailing)

37.5x

P/B

3.29x

EV/EBITDA

22.2x

PEG

0.64

Dividend Yield

None

What's Good / What's Bad

🟢 What's Going Well6

Margins are improving
EBITDA margin is up from 3.3% to 6.3% over 3 years.
Debt is being paid down
Total debt is down 11% over 3 years.
Return on equity is rising
ROE has improved from 4.5% to 12.8%.
Return on capital is rising
ROCE has improved from 12.9% to 20.6%.
High return on capital employed
ROCE of 20.6% is the mark of a business that converts capital into profit efficiently.
Consistently profitable
Profitable in every one of the last 4 reported years.

🔴 What Needs Attention0

Nothing stands out as clearly deteriorating on the years of data available.

Red Flags

No automated checks triggered

None of the automated financial checks below were triggered on the years of data available. That is not the same as a clean bill of health — see what could not be checked.

Investment Thesis

🟢 Bull CaseWhat could make this work?

Capital compounds at a high rate
ROCE of 20.6% means each rupee reinvested earns well above what capital costs. If the company can keep deploying at this rate, growth creates value rather than just consuming cash.
Margin expansion has further to run
EBITDA margin has risen from 3.3% to 6.3%. If that holds, profit compounds faster than sales and today's multiple looks cheaper in hindsight than it does now.
Cheaper than its peers
It trades 46% below the sector median. Either the market sees a problem the numbers do not show, or the discount closes.
Earnings have proved durable
Profitable in every one of the last 4 reported years. Consistency lowers the risk that any single bad year is structural rather than cyclical.

🔴 Bear CaseWhat could go wrong?

The debt load needs earnings to hold up
Debt is 3.1x EBITDA. At that level a downturn in earnings turns a manageable balance sheet into a refinancing problem, and lenders get paid before shareholders.
Growth barely outpaces inflation
Revenue compounding at 4.5% a year is close to the rate prices rise, so the business is gaining little ground in real terms. That leaves the share price dependent on a re-rating rather than on earnings growth.
Size brings its own risk
Micro Cap businesses are thinly traded, so exits are harder in a falling market and single events move the price more than they would for a larger company.

🟡 Key Things to WatchMeasurable tripwires, set against where this company stands today

1EBITDA margin holds above 4%✓ 6.3%
Two points below today's level — enough room for noise, tight enough to catch real compression.
2Debt / EBITDA falls below 3x✗ 3.1x
Already stretched, so this is a reduction target rather than a level to hold. Around 3x is where lenders typically start attaching conditions.
3Interest cover stays above 3x✓ 3.9x
How much operating profit can fall before interest stops being comfortably covered.
4Revenue growth stays above 4% a year✓ 4.5% CAGR
Latest reported year was 18.8%. The bar is set below the established compounding rate, so ordinary variation does not trip it.
5Free cash flow remains positive✓ ₹14 Cr
Profit that never becomes cash eventually stops being profit.

Investment Checklist

8 / 10 checks passed

✗ Strong return on equity (ROE ≥ 15%)
✓ Strong return on capital employed (ROCE ≥ 15%)
✗ Healthy net margin (≥ 10%)
✓ Generates positive free cash flow
✓ Manageable leverage (Debt/Equity < 1.0)
✓ Adequate short-term liquidity (Current Ratio ≥ 1.0)
✓ Revenue growing year-over-year
✓ Profit growing year-over-year
✓ Not trading at an extreme valuation (P/E < 40x)
✓ Not buying right at the 52-week high

Price history

Quick Metrics

5 good · 6 neutral · 0 weak

Market Cap

₹642 Cr

Micro Cap

Smaller company — thin liquidity and deep drawdowns are normal here

P/E (Trailing)

37.5x

Fair

Fairly valued against the generic band

P/B Ratio

3.29x

Fair

Moderate premium to the company's book value

EPS (TTM)

₹9.51

Profitable

Profitable on a per-share basis

ROE

12.8%

Moderate

Moderate capital efficiency

ROCE

20.6%

Strong

Earns comfortably above its likely cost of capital

Debt/Equity

0.77x

Moderate

Moderate leverage

Revenue Growth (YoY)

18.8%

Healthy

Healthy top-line growth

Profit Growth (YoY)

56.7%

Healthy

Profits growing at a healthy clip

Dividend Yield

None

No dividend yield reported — usually means no payout, but verify if one was recently initiated

Free Cash Flow

₹14 Cr

Cash generative

Generates cash even after funding its capex

More Metrics

CMP

₹356.75

Operating Margin

7.0%

Average

Average margins

Net Margin

3.6%

Average

Average bottom-line conversion

Current Ratio

1.91

Comfortable

Healthy short-term liquidity

52W Range Position

83%

Mid-range

Financial Trend (4-Year)

Metric	FY23	FY24	FY25	FY26	3Y CAGR
Revenue	₹464 Cr	₹407 Cr	₹432 Cr	₹529 Cr	+4.5%
EBITDA	₹15 Cr	₹19 Cr	₹25 Cr	₹34 Cr	+29.6%
EBITDA Margin	3.3%	4.7%	5.8%	6.3%	—
PAT (Net Profit)	₹4 Cr	₹7 Cr	₹11 Cr	₹18 Cr	+58.3%
EPS	₹2.5	₹0.11	₹5.84	₹9.9	+58.3%
ROE	4.5%	7.5%	10.0%	12.8%	—
ROCE	12.9%	17.6%	20.7%	20.6%	—
Total Debt	₹118 Cr	₹125 Cr	₹147 Cr	₹104 Cr	-3.9%
Free Cash Flow	₹13 Cr	-₹4 Cr	-₹1 Cr	₹14 Cr	+4.1%

🟢 Revenue has grown at 4.5% a year over 3 years.

🟢 EBITDA has grown at 29.6% a year over 3 years.

🟢 EBITDA Margin has risen from 3.3% to 6.3% over 3 years (+3.0 pts).

🟢 PAT (Net Profit) has grown at 58.3% a year over 3 years.

🟢 EPS has grown at 58.3% a year over 3 years.

🟢 ROE has risen from 4.5% to 12.8% over 3 years (+8.3 pts).

🟢 ROCE has risen from 12.9% to 20.6% over 3 years (+7.7 pts).

🟢 Total Debt has shrunk at 3.9% a year over 3 years.

🟢 Free Cash Flow has grown at 4.1% a year over 3 years.

Balance Sheet & Cash Flow — FY2026

Total Assets

₹292 Cr

Total Liabilities

₹153 Cr

Total Debt

₹104 Cr

Cash & Equivalents

₹3 Cr

Operating Cash Flow

₹18 Cr

Capex

-₹3 Cr

Shareholding (proxy)

Institutional Holding

2.4%

Insider Holding

75.5%

Peer Comparison

Company	P/E	ROE
TITAN COMPANY LIMITED	68.5x	36.7%
TRENT LTD	87.2x	25.9%
AVENUE SUPERMARTS LIMITED	69.9x	12.7%
ASIAN PAINTS LIMITED	46.9x	22.3%

Recent News

6 general

Priority Jewels IPO Oversubscribed 29x On Day 2: GMP Spikes 22%; Should You Apply For Listing Gains?

Goodreturns, 15 Oct

Compare with

Equitymaster, 15 Oct

PRIORITY Share Price near 52-week high; price, fundamentals

Univest, 12 Oct

Priority Jewels shares list at 15% premium over IPO price on NSE

Moneycontrol.com, 04 Sept

Priority Jewels shares list at 15% premium over IPO price. Check details

The Economic Times, 04 Sept

Priority Jewels sets IPO price band at ₹190-200/share; issue to open on Aug 28

BusinessLine, 24 Aug

Watch Items

Cross-check against the company's latest quarterly filing / investor presentation before acting.

DalalBaazaar Thesis

🟡Business QualityAdequate12.4/20

🟢Financial HealthStrong15.1/20

🟢GrowthStrong13.1/20

🟡ProfitabilityModerate8.5/15

🟡ValuationFair7.5/15

🔴RiskHigh1.8/10

Good business at a fair price

A sound business at a reasonable valuation. Suitable for a long-term holding, with the valuation and the direction of margins worth watching rather than the business itself.

This thesis breaks if

✓EBITDA margin holds above 4%6.3%
✗Debt / EBITDA falls below 3x3.1x
✓Interest cover stays above 3x3.9x
✓Revenue growth stays above 4% a year4.5% CAGR
✓Free cash flow remains positive₹14 Cr